Drug Discovery Today

Proteomics: key technology in drug discovery
pp. 193-195(3)
Author: Celis J.E.

Chiroscience/BMS MMP inhibitor progress
pp. 196-196(1)
Author: Bradley D.

InfoTech Pharma '98: managing the knowledge
pp. 197-199(3)
Author: Thorne M.

ERT cancer suspect?
pp. 200-200(1)
Author: Bradley D.

IL-6 as a drug discovery target
pp. 202-213(12)
Authors: Stein B.; Kung Sutherland M.S.

Allosteric modulators of ligand binding to muscarinic acetylcholine receptors
pp. 214-222(9)
Authors: Holzgrabe U.; Mohr K.

Factor Xa inhibitors by classical and combinatorial chemistry
pp. 223-231(9)
Authors: Al-Obeidi F.; Ostrem J.A.

Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development
pp. 232-238(7)
Author: Verpoorte R.

Monitor: molecules and profiles
pp. 239-240(2)
Author: Lloyd A.

Neuronal nicotinic ACh receptor modulators
pp. 240-241(2)
Author: Holladay M.W.

Combinatorial Chemistry
pp. 242-242(1)
Author: Terrett N.